Dr. Prasanth Manohar, Ph.D., – Page 43 – PHAGElogist

‘Super Viruses’ to treat superbugs

Can Phage Therapy be the potential answer? Bacteriophages also called phages are bacteria-attacking microorganisms that devour selected bacteria without causing any harm to the host. Phages are all around us…

Bacteriophages as prophylactic agents

Antibiotics are used as a prophylactic agents during this viral pandemic. In future, Can phage therapy be used as for empirical treatment? In study: Phages used for therapeutic or prophylactic…

Why SARS-CoV-2 is not the product of purposeful manipulation?

1. Mutations in the receptor-binding domain of SARS-CoV-2: The receptor binding domain (RBD) in the spike protein is the most variable part of the coronavirus genome. Six RBD amino acids…

Why “A Tiger tested positive for coronavirus” is nothing new?

Coronaviruses are not particularly hard to please when it comes to potential hosts -- they've been detected in many mammal and bird species, including dogs and cats, as well as…

Research sheds new light on the phage therapy history

In the current situation when the fear of virus infections in the public is common, it is good to remember that some viruses can be extremely beneficial for mankind, even…

SARS-CoV-2 is not escaped from the lab-Evidence

The proximal origin of SARS-CoV-2- Nature Medicine The genomic features described here may explain in part the infectiousness and transmissibility of SARS-CoV-2 in humans.Although the evidence shows that SARSCoV-2 is…

Replace antibiotics with programmable viruses

Right now the world is at war. But this is no ordinary war. It’s a fight with an organism so small we can only detect it through use of a…

FDA Clears First Clinical Study for a Polymicrobial Phage Library-Based Treatment for Antibiotic-Resistant Infections

21 Mar 202021 Mar 2020

--Three Clinical Sites to Enroll Patients with Recurrent and Complicated Urinary Tract Infections-- GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response…

Armata Receives Up to $5M From CF Foundation to Develop Phage Therapy AP-PA02

The Cystic Fibrosis Foundation has awarded up to $5 million to Armata Pharmaceuticals to advance its potential treatment AP-PA02 — a phage therapy against multidrug-resistant Pseudomonas aeruginosa infections in cystic…

How phage therapy can help recover from SARS-CoV-2 secondary infections?

Source: © Shutterstock The world is going through one of the scariest pandemic of all time or at least the biggest of this generation. COVID-19 is caused by corona virus…